Lv1
30 积分 2025-09-18 加入
Engineered Biomimetic Nanovesicles Derived From Bone Marrow Stromal Cells With Innate Homing Capability for Targeted Delivery
2天前
已完结
Neutrophil/Leukemia‐Tropic Dual‐Drug Nanomedicine Potentiates the Treatment of Acute Myeloid Leukemia
1个月前
已完结
Haematopoietic stem cell self-renewal in vivo and ex vivo
1个月前
已完结
Development and Characterization of Venetoclax Nanocrystals for Oral Bioavailability Enhancement
1个月前
已完结
Program of the World Health Organization and plans for the future
1个月前
已关闭
Mechano-oncogenic cytoskeletal remodeling drives leukemic transformation with mitochondrial vesicle-mediated STING activation
1个月前
已完结
A systematic review of second-generation FLT3 inhibitors for treatment of patients with relapsed/refractory acute myeloid leukemia
2个月前
已完结
Red blood cell membrane-coated FLT3 inhibitor nanoparticles to enhance FLT3-ITD acute myeloid leukemia treatment
2个月前
已完结
Quizartinib (Quiz) with Decitabine (DAC) and Venetoclax (VEN) Is Highly Active in Patients (pts) with FLT3-ITD Mutated Acute Myeloid Leukemia (AML) - RAS/MAPK Mutations Continue to Drive Primary and Secondary Resistance
2个月前
已完结
Single-Cell Proteomic Interrogation of FLT3-ITD Leukemia Compartment Revealsdistinct Leukemia Cell Populations Resistant to Quizartinib, Decitabine and Venetoclax
2个月前
已关闭
皖公网安备34019202002308
